We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Oral Contraceptive

News List

Mayne Pharma launches another generic oral contraceptive prnasia
March 05, 2021
Mayne Pharma Group Limited is pleased to announce the commercial launch of a generic version of ORTHO-CEPT® (desogestrel and ethinyl estradiol 0.15 mg / 0.03 mg) tablets to customers in the US.
Lyndra Therapeutics to create long-acting oral contraceptive pharmaceutical-technology
July 31, 2019
US-based Lyndra Therapeutics has revealed plans to develop a once-monthly oral contraceptive that will deliver a continuous dose of estrogen and progestin over multiple weeks.
FDA Accepts Filing of New Estrogen-free Oral Contraceptive Slinda (drospirenone) Developed by Exeltis drugs
December 03, 2018
The pharmaceutical multinational Exeltis, with a strong position in Women's Health, has received acceptance from the US Food and Drug Administration (FDA) of the filing.....